The Department of Medical Affairs reiterates that this wave of Covid patients cannotfavipiravir Who can check the conditions? According to the guideline for dispensing drugs for COVID-19 patients, the 24th revised edition (announcement of guidelines as of 11 July 65)
Dr. Somsak Ankasil, director-general of the Department of Medical Services, revealed that the current COVID-19 outbreak has a tendency to increase the number of infected people. Causing some people to have doubts about the guidelines for dispensing drugs for COVID-19 patients And there is a misunderstanding! that all patients must receive antiviral drugs (Favi, Molnu, Paxlovid)
The Department of Medicine confirmed that COVID-19 patients should be treated according to the treatment guidelines that the Medical Department cooperates with the faculty Qualified persons from various agencies and representatives of the medical team on duty There is a review and adjustment of patient care guidelines. According to academic information in the country and abroad continuously
At present, guidelines for medical practice, diagnosis, care and prevention of infection in hospitals have been announced. The case of coronavirus disease 2019 (COVID-19) for doctors and public health personnel, the 24th revised edition, dated 11 July 2022, is used to treat COVID-19 patients divided into 4 groups as follows:
- group without symptoms or well
Provide symptomatic care *Not giving antiviral drugs* by taking care of treatment as an outpatient by isolating at home (Out-patient with self Isolation) as most of them recover on their own. Your doctor may prescribe andrographis paniculata to relieve mild symptoms.
- Patients with mild symptoms no pneumonia No risk factors for severe disease/comorbid disease
Doctors may prescribe favipiravir during the first four days after symptoms appear, but if the patient has had symptoms for more than 5 days and has improved. Your doctor may not prescribe antiviral medications. Because the patient will heal on their own without complications.
- Patients with mild symptoms However, there were significant risk factors for severe disease/comorbid disease.
In addition, this included patients who had no risk factors but had mild to moderate pneumonia who did not require oxygen. In this group, the doctor may consider giving one type of antiviral drug since the onset of symptoms. based on the history of congenital disease Contraindications to the use of the drug interaction of antiretroviral drugs with the patient’s original drug
- Severe pneumonia need to be treated with oxygen
This group must be hospitalized for close monitoring of the patient’s condition. in accordance with the guidelines set forth in the medical practice guidelines The use of the drug should be under the supervision of a physician. Because all antiviral drugs are emergency use.
However, for the safety of people, families and communities, the best prevention of infection is vaccination and following Universal Prevention measures to prevent infection. especially wearing a mask when in the community, washing hands and keeping distance between people
——————————————
Reference: Department of Medical Services, Ministry of Public Health
